"10.1371_journal.pone.0065904","plos one","2013-05-30T00:00:00Z","Xin Zhou; Yan Ma; Yue Fang; Wugan gerile; Wurentuya Jaiseng; Yuki Yamada; Takayoshi Kuno","Department of Oncology, the First Affiliated Hospital of Liaoning Medical University, Jinzhou, China; Division of Molecular Pharmacology and Pharmacogenomics, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Kobe, Japan; Department of Pharmacology, School of Pharmaceutical Sciences, China Medical University, Shenyang, China","Conceived and designed the experiments: XZ YM YF TK. Performed the experiments: XZ YM YF Wg WJ YY. Analyzed the data: XZ YM YF Wg WJ YY TK. Contributed reagents/materials/analysis tools: XZ YM YF TK. Wrote the paper: XZ YM TK.","The authors declare that FK506 (tacrolimus) compound used in their research is a gift from a commercial source, Astellas Pharma Inc. This does not alter the authorsadherence to all the PLOS ONE policies on sharing data and materials.","2013","05","Xin Zhou","XZ",7,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
